Similar to the targeting of IL-6, anti-TNFα mAbs are used to treat inflammatory conditions, such as rheumatoid arthritis, juvenile arthritis, inflammatory bowel diseases, and psoriasis (reviewed in Refs. The gene discussed is IL6; the disease is juvenile idiopathic arthritis.